These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38061342)

  • 1. Integrating China in the International Consortium for Personalized Medicine: A Position Paper on Personalized Medicine in Sustainable Healthcare.
    Causio FA; Beccia F; Hoxhaj I; Huang HY; Wang L; Wang W; Farina S; Osti T; Savoia C; Cadeddu C; Ricciardi W; Boccia S
    Public Health Genomics; 2024; 27(1):1-11. PubMed ID: 38061342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Integrating China in the International Consortium for Personalized Medicine": The Coordination and Support Action to Foster Collaboration in Personalized Medicine Development between Europe and China.
    Morsella A; Cadeddu C; Castagna C; Hoxhaj I; Sassano M; Wang CM; Wang L; Klessova S; de Belvis AG; Boccia S; Ricciardi W
    Public Health Genomics; 2021; 24(5-6):310-314. PubMed ID: 34392247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of Personalized Medicine landscape and policies in the European Union.
    Beccia F; Hoxhaj I; Castagna C; Strohäker T; Cadeddu C; Ricciardi W; Boccia S
    Eur J Public Health; 2022 Nov; 32(6):844-851. PubMed ID: 36305782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine.
    Beccia F; Di Marcantonio M; Causio FA; Schleicher L; Wang L; Cadeddu C; Ricciardi W; Boccia S
    BMC Public Health; 2024 Feb; 24(1):464. PubMed ID: 38355452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of experts on personalized medicine landscape in European Union and China.
    Hoxhaj I; Beccia F; Morsella A; Cadeddu C; Ricciardi W; Boccia S
    BMC Health Serv Res; 2023 May; 23(1):517. PubMed ID: 37221524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating China in the international consortium for personalised medicine. a position paper on healthcare professionals' education and citizens' empowerment in personalised medicine.
    Beccia F; Causio FA; Hoxhaj I; Huang HY; Wang L; Wang W; Farina S; Osti T; Savoia C; Cadeddu C; Ricciardi W; Boccia S
    BMC Med Educ; 2023 Jun; 23(1):438. PubMed ID: 37316817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Big data and ICT solutions in the European Union and in China: A comparative analysis of policies in personalized medicine.
    Causio FA; Hoxhaj I; Beccia F; Di Marcantonio M; Strohäker T; Cadeddu C; Ricciardi W; Boccia S
    Digit Health; 2022; 8():20552076221129060. PubMed ID: 36329830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research and innovation in personalized medicine: a descriptive synthesis of actors in the EU and China.
    Causio FA; Hoxhaj I; Beccia F; Marcantonio MD; Strohäker T; Cadeddu C; Ricciardi W; Boccia S
    Per Med; 2023 May; 20(3):227-238. PubMed ID: 37195152
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of precision medicine in healthcare-A European perspective.
    Stenzinger A; Moltzen EK; Winkler E; Molnar-Gabor F; Malek N; Costescu A; Jensen BN; Nowak F; Pinto C; Ottersen OP; Schirmacher P; Nordborg J; Seufferlein T; Fröhling S; Edsjö A; Garcia-Foncillas J; Normanno N; Lundgren B; Friedman M; Bolanos N; Tatton-Brown K; Hill S; Rosenquist R
    J Intern Med; 2023 Oct; 294(4):437-454. PubMed ID: 37455247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
    Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
    Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Roadmap toward Personalized Medicine: Challenges and Opportunities.
    Cinti C; Trivella MG; Joulie M; Ayoub H; Frenzel M;
    J Pers Med; 2024 May; 14(6):. PubMed ID: 38929767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sino-European science and technology collaboration on personalized medicine: overview, trends and future perspectives.
    Romagnuolo I; Mariut C; Mazzoni A; Santis G; Moltzen E; Ballensiefen W; Lange C; Frosini A; D'Errico G
    Per Med; 2021 Sep; 18(5):455-470. PubMed ID: 34060340
    [No Abstract]   [Full Text] [Related]  

  • 13. How personalised medicine will transform healthcare by 2030: the ICPerMed vision.
    Vicente AM; Ballensiefen W; Jönsson JI
    J Transl Med; 2020 Apr; 18(1):180. PubMed ID: 32345312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International consortium for personalized medicine: an international survey about the future of personalized medicine.
    Venne J; Busshoff U; Poschadel S; Menschel R; Evangelatos N; Vysyaraju K; Brand A
    Per Med; 2020 Mar; 17(2):89-100. PubMed ID: 32154758
    [No Abstract]   [Full Text] [Related]  

  • 15. Current landscape of personalized medicine adoption and implementation in Southeast Asia.
    Chong HY; Allotey PA; Chaiyakunapruk N
    BMC Med Genomics; 2018 Oct; 11(1):94. PubMed ID: 30367635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of personalized healthcare and the pivotal role of European regions in its implementation.
    Nardini C; Osmani V; Cormio PG; Frosini A; Turrini M; Lionis C; Neumuth T; Ballensiefen W; Borgonovi E; D'Errico G
    Per Med; 2021 May; 18(3):283-294. PubMed ID: 33825526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
    Schee Genannt Halfmann S; Evangelatos N; Schröder-Bäck P; Brand A
    Per Med; 2017 Jan; 14(1):63-74. PubMed ID: 29749826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese villages and their sustainable future: the European Union-China-Research Project "SUCCESS".
    Dumreicher H
    J Environ Manage; 2008 Apr; 87(2):204-15. PubMed ID: 17888563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling personalized medicine in Europe by the European Commission's funding activities.
    Nimmesgern E; Norstedt I; Draghia-Akli R
    Per Med; 2017 Jul; 14(4):355-365. PubMed ID: 29749834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Integrate Personalized Medicine into Prevention? Recommendations from the Personalized Prevention of Chronic Diseases (PRECeDI) Consortium.
    Boccia S; Pastorino R; Ricciardi W; Ádány R; Barnhoorn F; Boffetta P; Cornel MC; De Vito C; Gray M; Jani A; Lang M; Roldan J; Rosso A; Sánchez JM; Van Dujin CM; Van El CG; Villari P; Zawati MH
    Public Health Genomics; 2019; 22(5-6):208-214. PubMed ID: 31805565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.